Hepatocyte growth factor gene-modified bone marrow-derived mesenchymal stem cells transplantation promotes angiogenesis in a rat model of hindlimb ischemia

Journal of Huazhong University of Science and Technology - Medical Science

Volumn 33, Issue 4, 2013, Pages 511-519

  Su, Guan Hua ^a   Sun, Yu Fei ^a   Lu, Yong Xin ^a   Shuai, Xin Xin ^a   Liao, Yu Hua ^a   Liu, Qi Yun ^a   Han, Jun ^a   Luo, Ping ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

angiogenesis; gene therapy; hepatocyte growth factor; mesenchymal stem cell; peripheral arterial disease

Indexed keywords

SCATTER FACTOR;

ANGIOGENESIS; ANIMAL; ARTICLE; BONE MARROW; BONE MARROW TRANSPLANTATION; CELL CULTURE; GENETICS; HINDLIMB; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; METABOLISM; PATHOLOGY; RAT;

ANIMALS; BONE MARROW; BONE MARROW TRANSPLANTATION; CELLS, CULTURED; HEPATOCYTE GROWTH FACTOR; HINDLIMB; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; NEOVASCULARIZATION, PHYSIOLOGIC; RATS;

EID: 84881309158     PISSN: 16720733     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11596-013-1151-6     Document Type: Article

References (38)

1. Belch JJ, Topol EJ, Agnelli G, et al. Critical issues in peripheral arterial disease detection and management: a call to action. Arch Intern Med, 2003,163(8):884-892
2. Weitz JI, Byrne J, Clagett GP, et al. Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review. Circulation, 1996,94(11): 3026-3049
3. Bobek V, Taltynov O, Pinterova D, et al. Gene therapy of the ischemic lower limb-Therapeutic angiogenesis. Vascul Pharmacol, 2006,44(6):395-405
4. Dormandy JA, Rutherford RB. Management of peripheral arterial disease(PAD). TASC Working Group. TransAtlantic Inter-Society Consensus(TASC). J Vasc Surg, 2000,31(1 Pt 2):S1-S296
5. Hamou C, Callaghan MJ, Thangarajah H, et al. Mesenchymal stem cells can participate in ischemic neovascularization. Plast Reconstr Surg, 2009,123(2 Suppl):45S-55S
6. Al-Khaldi A, Al-Sabti H, Galipeau J, et al. Therapeutic angiogenesis using autologous bone marrow stromal cells: improved blood flow in a chronic limb ischemia model. Ann Thorac Surg, 2003,75(1):204-209
7. Kinnaird T, Stabile E, Burnett MS, et al. Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation, 2004,109(12):1543-1549
8. Iwase T, Nagaya N, Fujii T, et al. Comparison of angiogenic potency between mesenchymal stem cells and mononuclear cells in a rat model of hindlimb ischemia. Cardiovasc Res, 2005,66(3):543-551
9. Picinich SC, Mishra PJ, Glod J, et al. The therapeutic potential of mesenchymal stem cells. Cell- & tissue-based therapy. Expert Opin Biol Ther, 2007,7(7):965-973
10. Ozawa K, Sato K, Oh I, et al. Cell and gene therapy using mesenchymal stem cells(MSCs). J Autoimmun, 2008,30(3):121-127
11. Kim SW, Lee DW, Yu LH, et al. Mesenchymal stem cells overexpressing GCP-2 improve heart function through enhanced angiogenic properties in a myocardial infarction model. Cardiovasc Res, 2012,95(4):495-506
12. Morishita R, Nakamura S, Hayashi S, et al. Therapeutic angiogenesis induced by human recombinant hepatocyte growth factor in rabbit hind limb ischemia model as cytokine supplement therapy. Hypertension, 1999,33(6):1379-1384
13. Wang S, Qin X, Sun D, et al. Effects of hepatocyte growth factor overexpressed bone marrow-derived mesenchymal stem cells on prevention from left ventricular remodelling and functional improvement in infarcted rat hearts. Cell Biochem Funct, 2012,30(7): 574-581
14. Cho KR, Choi JS, Hahn W, et al. Therapeutic angiogenesis using naked DNA expressing two isoforms of the hepatocyte growth factor in a porcine acute myocardial infarction model. Eur J Cardiothorac Surg, 2008,34(4):857-863
15. Yuan B, Zhao Z, Zhang YR, et al. Short-term safety and curative effect of recombinant adenovirus carrying hepatocyte growth factor gene on ischemic cardiac disease. In Vivo, 2008,22(5):629-632
16. Nakamura Y, Morishita R, Nakamura S, et al. A vascular modulator, hepatocyte growth factor, is associated with systolic pressure. Hypertension, 1996,28(3):409-413
17. Matsumoto R, Omura T, Yoshiyama M, et al. Vascular endothelial growth factor-expressing mesenchymal stem cell transplantation for the treatment of acute myocardial infarction. Arterioscler Thromb Vasc Biol, 2005,25(6):1168-1173
18. Kinnaird TD, Stabile E, Burnett MS, et al. HIF-1alpha/VP16 enhances the in-vitro arteriogenic potential of mesenchymal stem cells. Circulation, 2003,108:337A
19. Li L, Zhang Y, Li Y, et al. Mesenchymal stem cell transplantation attenuates cardiac fibrosis associated with isoproterenol-induced global heart failure. Transpl Int, 2008,21(12):1181-1189
20. Dull T, Zufferey R, Kelly M, et al. A third-generation lentivirus vector with a conditional packaging system. J Virol, 1998,72(11):8463-8471
21. Hobo K, Shimizu T, Sekine H, et al. Therapeutic angiogenesis using tissue engineered human smooth muscle cell sheets. Arterioscler Thromb Vasc Biol, 2008,28(4):637-643
22. Wang JS, Shum-Tim D, Galipeau J, et al. Marrow stromal cells for cellular cardiomyoplasty: feasibility and potential clinical advantages. J Thorac Cardiovasc Surg, 2000,120(5):999-1005
23. Duan HF, Wu CT, Wu DL, et al. Treatment of myocardial ischemia with bone marrow-derived mesenchymal stem cells overexpressing hepatocyte growth factor. Mol Ther, 2003,8(3):467-474
24. Yang ZJ, Ma DC, Wang W, et al. Experimental study of bone marrow-derived mesenchymal stem cells combined with hepatocyte growth factor transplantation via noninfarct-relative artery in acute myocardial infarction. Gene Ther, 2006,13(22):1564-1568
25. Zhao MZ, Nonoguchi N, Ikeda N, et al. Novel therapeutic strategy for stroke in rats by bone marrow stromal cells and ex vivo HGF gene transfer with HSV-1 vector. J Cereb Blood Flow Metab, 2006,26(9):1176-1188
26. Guo Y, He J, Wu J, et al. Locally overexpressing hepatocyte growth factor prevents post-ischemic heart failure by inhibition of apoptosis via calcineurin-mediated pathway and angiogenesis. Arch Med Res, 2008,39(2):179-188
27. Bian L, Guo ZK, Wang HX, et al. In vitro and in vivo immunosuppressive characteristics of hepatocyte growth factor-modified murine mesenchymal stem cells. In Vivo, 2009,23(1):21-27
28. Neuss S, Becher E, Woltje M, et al. Functional expression of HGF and HGF receptor/c-met in adult human mesenchymal stem cells suggests a role in cell mobilization, tissue repair, and wound healing. Stem Cells, 2004,22(3):405-414
29. Cai L, Johnstone BH, Cook TG, et al. Suppression of hepatocyte growth factor production impairs the ability of adipose-derived stem cells to promote ischemic tissue revascularization. Stem Cells, 2007,25(12):3234-3243
30. Sakon M, Kita Y, Yoshida T, et al. Plasma hepatocyte growth factor levels are increased in systemic inflammatory response syndrome. Surg Today, 1996,26(4):236-241
31. Rosu-Myles M, Stewart E, Trowbridge J, et al. A unique population of bone marrow cells migrates to skeletal muscle via hepatocyte growth factor/c-met axis. J Cell Sci, 2005,118(Pt 19):4343-4352
32. Forte G, Minieri M, Cossa P, et al. Hepatocyte growth factor effects on mesenchymal stem cells: proliferation, migration, and differentiation. Stem Cells, 2006,24(1): 23-33
33. Aoki M, Morishita R, Taniyama Y, et al. Angiogenesis induced by hepatocyte growth factor in non-infarcted myocardium and infarcted myocardium: up-regulation of essential transcription factor for angiogenesis, ets. Gene Ther, 2000,7(5):417-427
34. Van Belle E, Witzenbichler B, Chen D, et al. Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor: the case for paracrine amplification of angiogenesis. Circulation, 1998,97(4):381-390
35. Xin X, Yang S, Ingle G, et al. Hepatocyte growth factor enhances vascular endothelial growth factor-induced angiogenesis in vitro and in vivo. Am J Pathol, 2001,158(3):1111-1120
36. Zhu XY, Zhang XZ, Xu L, et al. Transplantation of adipose-derived stem cells overexpressing hHGF into cardiac tissue. Biochem Biophys Res Commun, 2009,379(4):1084-1090
37. Morishita R. Recent progress in gene therapy for cardiovascular disease. Circ J, 2002,66(12):1077-1086
38. Kinnaird T, Stabile E, Burnett MS, et al. Bone-marrow-derived cells for enhancing collateral development: mechanisms, animal data, and initial clinical experiences. Circ Res, 2004,95(4):354-363